Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-25-090431

Chief Legal Officer sold 11,491 shares at $6.80 ($78,139)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sullivan Mark · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-25 Sale : show line 1 in the form 10b5-1 −11,491 $6.80 $78,139 305,130 D
Open-market sales · 11,491 sh · avg $6.80 · $78,139
Loading xslF345X05/ownership.xml…